AVEO Pharma (AVEO) Says Partner Astellas Won't Submit Tivozani to EMA, Won't Fund Future Trials
Tweet Send to a Friend
AVEO Pharmaceuticals (NASDAQ: AVEO) said it was informed by its partner, Astellas Pharma Inc., that Astellas no longer ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


